Leuven Tolerogenic Protocol for Intestinal Transplantation
A Multifactorial Immunomodulatory Protocol -Promoting T-regulatory Cells- Prolongs Graft and Patient Survival After Intestinal Transplantation
Universitaire Ziekenhuizen KU Leuven
13 participants
Oct 1, 2000
OBSERVATIONAL
Conditions
Summary
An immunomodulatory protocol, experimentally-proven to promote T-regulatory dependent graft protective mechanisms was applied in a clinical cohort of 13 intestinal transplant recipients to activate - in a protolerogenic environment - T-regulatory cells. This protocol is the standard of care in the investigators intestinal transplant programme since the first intestinal transplant was performed in october 2000.
Eligibility
Inclusion Criteria1
- all patients awaiting intestinal transplantation
Exclusion Criteria1
- living donation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02314949